Initiatives to Develop Compact and Multimodal Imaging Systems and High Prevalence of Chronic Diseases to Augment Growth of Life Science Microscopy Devices Market
Initiatives to develop compact and multimodal imaging systems is expected to propel growth of the global life science microscopy devices market. For instance, in December 2020, a new European research project called CARMEN announced its objective to improve the detection of cancerous cells during surgery. Under the project, the research institutes Laser Zentrum Hannover, Germany, and Multitel, Belgium are working with companies from both countries, JenLab, Deltatec, and LaserSpec, to develop a compact and multimodal imaging system.
High
prevalence of chronic diseases is expected to offer lucrative growth
opportunities for players in the global life science microscopy devices market.
For instance, according to the study, “Global and regional diabetes prevalence
estimates for 2019 and projections for 2030 and 2045: Results from the
International Diabetes Federation Diabetes Atlas, 9th edition”, published in
the journal Diabetes Research and Clinical Practice, in September 2019, 463
million people are expected to suffer from diabetes in 2019 worldwide and the
number is expected to reach 578 million by 2030 and 700 million by 2045.
High
cost of microscopy devices is expected to limit growth of the life science
microscopy devices market. For instance, Helios NanoLab Dual Beam SEM from FEI
Company sells at US$ 2.2 million, Libra 200 TEM from Zeiss is priced at US$ 2.5
million, and Titan G2 80-200 scanning transmission electron microscope (S/TEM)
at US$ 12.8 million. Moreover, product recalls are also expected to hinder
growth of the market. For instance, in October 2019, Beckman Coulter Inc.
recalled iQ200 Series Urine Microscopy Analyzer, owing to reported incidents
where two sets of results report the same Specimen Identifier with different
results, different Medical Record Number and different patient identification.
Among
regions, North America is expected to witness significant growth in the life
science microscopy devices market, owing to increasing prevalence of ocular disorders
in the region. For instance, according to National Eye Institute’s projections,
the number of people in the U.S. with cataract is expected to reach 50 million
in 2050.
Competitive Analysis
Major
players operating in the global life science microscopy devices market include,
Olympus Corporation, Thermo fisher Scientific, Inc., Nikon Corporation, Carl
Zeiss AG, Keyence Corporation, JEOL Ltd., Leica Microsystems, Bruker, Hitachi
High-Technologies Corporation, Leica Microsystems, and F. Hoffman-La Roche Ltd.
Major
players in the life science microscopy devices market are focused on adopting
collaboration and partnership strategies to enhance their market share. For
instance, in December 2019, Leica Microsystems collaborated with the European
Molecular Biology Laboratory for the development of new imaging technologies.
Comments
Post a Comment